Yorktown Management & Research Company’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-10,400
| Closed | -$778K | – | 236 |
|
|
2021
Q4 | $778K | Hold |
10,400
| – | – | 0.53% | 42 |
|
|
2021
Q3 | $591K | Hold |
10,400
| – | – | 0.44% | 67 |
|
|
2021
Q2 | $458K | Buy |
10,400
+5,900
| +131% | +$260K | 0.36% | 122 |
|
|
2021
Q1 | $222K | Buy |
+4,500
| New | +$222K | 0.18% | 226 |
|
|
2020
Q4 | – | Sell |
-4,500
| Closed | -$206K | – | 231 |
|
|
2020
Q3 | $206K | Hold |
4,500
| – | – | 0.19% | 235 |
|
|
2020
Q2 | $226K | Hold |
4,500
| – | – | 0.2% | 247 |
|
|
2020
Q1 | $231K | Buy |
+4,500
| New | +$231K | 0.23% | 186 |
|
|
2019
Q3 | – | Sell |
-6,034
| Closed | -$509K | – | 311 |
|
|
2019
Q2 | $509K | Hold |
6,034
| – | – | 0.19% | 142 |
|
|
2019
Q1 | $576K | Hold |
6,034
| – | – | 0.19% | 139 |
|
|
2018
Q4 | $427K | Buy |
6,034
+358
| +6% | +$25.3K | 0.14% | 163 |
|
|
2018
Q3 | $485K | Buy |
5,676
+479
| +9% | +$40.9K | 0.14% | 165 |
|
|
2018
Q2 | $602K | Buy |
+5,197
| New | +$602K | 0.17% | 137 |
|